Article | January 1, 2022

Compelling Advantages Of Creating A Patient-Centric Supply Chain

By Nina Vas, Vice President, Clinical Distribution, Marken


In 2020, the prospect of shipping perishable COVID-19 vaccines around the globe pushed the pharmaceutical cold chain into the spotlight. The requirement for trustworthy, climate-controlled transportation and storage at an unprecedented scale and reach called attention to the complexities surrounding the worldwide distribution of temperature-sensitive medicines and clinical trial materials (CTMs).

Patient wellbeing and clinical trial success both hinge on efficient, compliant CTM distribution and administration. When combined with robust infrastructure, global experience, and innovative packaging solutions, the storage of supplies and clinical drug products close to patients, when appropriate, can be a key strategy.

Marken’s Vice President, Clinical Distribution, Nina Vas, discusses everything from global regulatory and trade compliance proficiency to the importance of a secure, closed-loop environment as she evaluates what is needed to develop a patient-centric supply chain.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader